Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.6B | 1.4B | 4.1B | 4.1B |
| Cost of revenue | 1.7B | 585M | 2.2B | 2.2B |
| Gross profit | 1.9B | 775M | 1.8B | 1.9B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 1.7B | 652M | 1.6B | 1.6B |
| Non operating interest income | ||||
| Income | 51M | 307M | 89M | 69M |
| Expense | 592M | 558M | 626M | 659M |
| Other income expense | 348M | 622M | 932M | 322M |
| Pretax income | 1.5B | 865M | 2.0B | 1.3B |
| Tax provision | 293M | 78M | 351M | 200M |
| Net income | 1.2B | 1.2B | 1.7B | 1.1B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 2.7B | 1.8B | 2.9B | 2.7B |
| Net income from continuing op. | 1.2B | 1.2B | 1.7B | 1.1B |
| Minority interests | -169M | -183M | -168M | -159M |
| Preferred stock dividends | — | — | — | — |